{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:19:54Z","timestamp":1789870794272,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jneuroim.2009.01.025","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T01:30:51Z","timestamp":1235266251000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Curative properties of antibodies against prion protein: A comparative in vitro study of monovalent fragments and divalent antibodies"],"prefix":"10.1016","volume":"209","author":[{"given":"Coralie","family":"Alexandrenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Hanoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Dkhissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Boquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Couraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wijkhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2009.01.025_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-1759(00)00135-6","article-title":"Papain digestion of different mouse IgG subclasses as studied by electrospray mass spectrometry","volume":"237","author":"Adamczyk","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14760584.6.2.153","article-title":"Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies","volume":"6","author":"Bade","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0958-1669(02)00352-X","article-title":"Pharmacokinetics and biodistribution of genetically engineered antibodies","volume":"13","author":"Batra","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198501103120202","article-title":"Creutzfeldt\u2013Jakob disease prion proteins in human brains","volume":"312","author":"Bockman","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0166-2236(02)02263-4","article-title":"Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators","volume":"25","author":"Checler","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib6","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1073\/pnas.151242598","article-title":"Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody","volume":"98","author":"Enari","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib7","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1074\/jbc.M407006200","article-title":"Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells","volume":"280","author":"F\u00e9raudet","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-1759(89)90223-8","article-title":"Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media","volume":"123","author":"Grassi","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003088-200342080-00002","article-title":"Pharmacokinetic\u2013pharmacodynamic relationships of immunoglobulin therapy for envenomation","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tibtech.2007.05.001","article-title":"Engineering antibodies for clinical applications","volume":"25","author":"Jain","year":"2007","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib12","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/bit.260191109","article-title":"Preparation and properties of immobilized papain and lipase","volume":"19","author":"Kilara","year":"1977","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib13","doi-asserted-by":"crossref","first-page":"24589","DOI":"10.1074\/jbc.270.41.24589","article-title":"A mutant prion protein displays an aberrant membrane association when expressed in cultured cells","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt\u2013Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/86562","article-title":"Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie","volume":"7","author":"Mabbott","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib16","doi-asserted-by":"crossref","first-page":"30143","DOI":"10.1074\/jbc.M403896200","article-title":"Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrils","volume":"279","author":"Morel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib17","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.79.7.4033-4042.2005","article-title":"Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP","volume":"79","author":"Nikles","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/JVI.74.1.320-325.2000","article-title":"Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein","volume":"74","author":"Nishida","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib19","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.molimm.2006.09.035","article-title":"Expression and detection strategies for an scFv fragment retaining the same high affinity than Fab and whole antibody: implications for therapeutic use in prion diseases","volume":"44","author":"Padiolleau-Lefevre","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35089090","article-title":"Antibodies inhibit prion propagation and clear cell cultures of prion infectivity","volume":"412","author":"Peretz","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1471-4159.2004.02356.x","article-title":"Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation","volume":"89","author":"Perrier","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib23","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0404772101","article-title":"Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection","volume":"101","author":"Polymenidou","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2006.01.026","article-title":"Engineering of therapeutic antibodies to minimize immunogenicity and optimize function","volume":"58","author":"Presta","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib25","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0022-1759(87)90180-3","article-title":"A simple, non-chromatographic purification procedure for monoclonal antibodies. Isolation of monoclonal antibodies against cytochrome P450 isozymes","volume":"100","author":"Reik","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib27","doi-asserted-by":"crossref","first-page":"30221","DOI":"10.1074\/jbc.270.50.30221","article-title":"Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells","volume":"270","author":"Shyng","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.imlet.2006.05.009","article-title":"Molecular aspects of human FcgammaR interactions with IgG: functional and therapeutic consequences","volume":"106","author":"Siberil","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib29","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1126\/science.1094273","article-title":"Cross-linking cellular prion protein triggers neuronal apoptosis in vivo","volume":"303","author":"Solforosi","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib30","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1074\/jbc.M610051200","article-title":"Toward molecular dissection of PRPC\u2013PRPSc interaction","volume":"282","author":"Solforosi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib31","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1099\/vir.0.83578-0","article-title":"Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice","volume":"89","author":"Song","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2006.03.001","article-title":"Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases","volume":"105","author":"Tayebi","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib33","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","article-title":"A systematic review of prion therapeutics in experimental models","volume":"129","author":"Trevitt","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2009.01.025_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1042\/bst0300512","article-title":"Formatting antibody fragments to mediate specific therapeutic functions","volume":"30","author":"Weir","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jneuroim.2009.01.025_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:12:25Z","timestamp":1759047145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809000290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0165572809000290"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.01.025","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curative properties of antibodies against prion protein: A comparative in vitro study of monovalent fragments and divalent antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}